OKYO Pharma Limited (NASDAQ:OKYO) Financings

OKYO Pharma Limited

Financings

RaiseDate
Public offering of ordinary shares
Announced: US$20M–US$23M · US$1.85 a share · Piper Sandler & Co.
Dealers: Piper Sandler & Co. (lead)
Use of proceeds: Clinical development of its product candidates, general corporate purposes and working capital
Feb 13, 2026
At-the-market programme of common shares
Announced: Leerink Partners LLC
Dealers: Leerink Partners LLC (lead)
Use of proceeds: Support ongoing clinical development and corporate objectives
Feb 11, 2026

Read by 6ix AI from the company's releases